{
    "2019-03-26": [
        [
            {
                "time": "2019-04-25",
                "original_text": "AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan",
                "features": {
                    "keywords": [
                        "Skyrizi",
                        "approval",
                        "Japan"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-26",
                "original_text": "Health Care Select Sector SPDR Fund Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "Health Care Select Sector SPDR Fund",
                        "big inflow"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-27",
                "original_text": "Were Hedge Funds Right About AbbVie Inc (ABBV)?",
                "features": {
                    "keywords": [
                        "hedge funds",
                        "AbbVie",
                        "right"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-28",
                "original_text": "The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",
                "features": {
                    "keywords": [
                        "Japanese cheer",
                        "AbbVie",
                        "Myokardia",
                        "CytomX"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-29",
                "original_text": "AbbVie Announces First Regulatory Approval of SKYRIZIâ„¢ (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan",
                "features": {
                    "keywords": [
                        "SKYRIZI",
                        "approval",
                        "treatment",
                        "Japan"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "dips",
                        "broader markets"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}